Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

CTI slumps as Servier-partnered lymphoma drug fails

After major setback CTI, has promising myelofibrosis candidate to fall back on

Creativity has lost its worth

Creativity has lost its worth, and sadly it is undermining effectiveness

Page & Page Health

Healthcare Comms appointments

Cuttsy+Cuttsy appoints new director, Porterhouse Medical adds to team and TBWAWorldHealth London sees Andy Hayley and Dick Dunford return

- PMLiVE

Daily Brief: Resignation throws Brexit into disarray, Celgene exec joins Orchard board, Scotland rules on EUSA drug

News from pharma, biotech and healthcare

- PMLiVE

NHS England says yes to Roche’s Hemlibra

But stalls on funding for Actelion's Uptravi

- PMLiVE

Axovant licenses another gene therapy as new strategy beds in

Group pursues gene therapy strategy

- PMLiVE

Communiqué: big wins for obesity and sugar tax campaigners

More highlights from healthcare communications awards

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

Training the next generation of biotech leaders

Blue Latitude Health speaks to Dr Ivan Wall, Reader in Cell & Gene Therapy Bioprocessing at University College London, to find out about the future of cell and gene therapy,...

Blue Latitude Health

- PMLiVE

New ABPI president pledges closer collaboration with NHS

UK pharma body appoints a president and vice president for the first time

- PMLiVE

Daily Brief: Crunch time for Brexit, GSK CEO RSVP from Trump

A round up from pharma, biotech and healthcare

Biogen Idec building

Biogen and Eisai claim mid-stage win for Alzheimer’s drug

Says drug slowed down progression of cognitive decline

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links